HALO military free-fall operator at altitude
Metakosmos / Human Systems Infrastructure Platform / Air Domain

The human is the least instrumented system at altitude.

Continuous physiological telemetry for HALO / HAHO operations and high-altitude flight — and why the published evidence says the current model is failing.

Every high-altitude platform in service is exhaustively instrumented. The person inside it is not. Cabin pressure, oxygen flow and airframe state are sampled continuously and logged. The operator's saturation, decompression load, thermal state and cognitive capacity are reconstructed afterwards — from a debrief, an incident report, or a hospital scan.

rise in U-2 DCS risk per flight, 2006–10
71physiological episodes / 100,000 T-45 hrs, 2017
>80%DCS at 25,000 ft over 4 hrs, no prebreathe
43 suseful consciousness on air at 35,000 ft
Evidence base

What the data shows

01 / Aviation

Decompression sickness is not a solved problem. It scales with operational tempo.

Across 1994–2010 there were 73 documented DCS cases among U-2 pilots, whose cabins sit at a pressure equivalent to roughly 29,500 ft. Risk per flight rose from 0.076% to 0.23%. Severe neurologic and pulmonary presentations more than doubled — 22 cases in five years against 10 in the preceding twelve. The increase tracked sortie frequency, not equipment failure.

Hundemer et al., Aviat Space Environ Med 2012; Jersey et al., 2011.

02 / Neurology

The injury persists after the sortie ends.

Imaging of high-altitude pilots treated for neurological DCS found a high burden of white-matter hyperintensities. Separate work reported measurably lower neurocognitive performance in U-2 pilots than in aircrew without repeated hypobaric exposure. One near-fatal in-flight case left permanent cognitive deficit with lesions visible on MRI. Repeated sub-clinical exposure appears to accumulate.

McGuire et al., 2012; Jersey et al., 2010; Neurology, 2014.

03 / Free fall

In HALO and HAHO the margin is procedural, not measured.

Jumpmasters are routinely exposed to 29,500 ft for around an hour, with drops conducted above 32,000 ft. Chamber studies report DCS incidence above 80% during a four-hour exposure to 25,000 ft without prebreathe. Structured exercise-enhanced prebreathe cut incidence to 25%, against 63% for an equal-duration resting protocol. Prebreathe effectiveness varies by individual and by execution — and is today assumed rather than verified.

Eiken et al., Eur J Appl Physiol 2023; Ottestad et al., J Appl Physiol 2017.

The common factor

In every finding above, the aircraft was instrumented and the human was not.

When the US Navy set out to explain a physiological-episode rate that reached 71 per 100,000 flight hours in the T-45 in 2017 — the highest ever recorded — it took roughly three years, about US$50 million, more than 8,000 pages of analysis and 567 recommendations. The root cause was a complex interaction between aircrew, life-support equipment and aircraft. The investigation cost what it did because the human side of that interaction had never been continuously recorded.

What changes

The Metakosmos approach

Metakosmos builds suits as platforms. Garment, life-support stack, sensing layer, validation programme and analytics are engineered as one system — so every sortie and every jump becomes a measured event with a traceable record, rather than a procedure assumed to have worked.

Oxygenation

Continuous SpO₂ and end-tidal CO₂ through mask and sensing garment — hypoxia onset detected before the operator can self-report it.

Decompression load

Prebreathe verification, cumulative hypobaric exposure and DCS-precursor modelling, personalised rather than applied as a fleet-wide assumption.

Thermal state

Core and skin temperature with extremity perfusion across a −45 °C envelope; cold degradation surfaced in real time.

Cognitive & cardiac

Heart-rate variability, workload and acceleration response — the variables that determine whether a correct decision is still available.

Platform

Two views of one platform

Engineering view

The test, laboratory and field-trial environment — built for the engineers who have to prove the claim.

  • Protocol versioning and traceable test records
  • Requirement-to-evidence chain, auditable on demand
  • Exportable evidence packages for certification
Operator view

The live operational dashboard, configurable by domain — air, space, sea and land.

  • Intervention-grade alerting to the operator, full record to the ground
  • Jumpmaster and flight-surgeon views at differing density
  • Sub-250 ms sensor-to-alert design target

Both are sensor-agnostic by design. Neither requires a Metakosmos suit to generate value — an operator can instrument the crews and jumpers they already have, on the equipment they already fly.

Testing framework

Validation programme

Altitude & decompression

Hypobaric exposure to 35,000 ft equivalent; prebreathe verification; DCS bubble-detection screening; cognitive task batteries under simulated altitude.

Wind blast & freefall

Vertical wind-tunnel characterisation at 150–250 mph; equipment retention; helmet and mask seal integrity under aerodynamic load.

Thermal & frostbite

Cold-soak to −50 °C; extremity perfusion under sustained cold exposure; skin-temperature mapping.

Standards alignment

FAA Part 105 / CASA Part 105; USPA B/C/D licensing and SIM oxygen procedures; AFI 11-409 and NATO STANAG free-fall doctrine; MIL-STD-810; MIL-STD-1472; DO-160.

How to engage

Next steps

Technical briefing

A closed session with the CTO and human-systems lead, worked against your operational profile. Outcome: capability brief and Q&A record.

Instrumented evaluation

Instrumented sorties or jumps flown on your equipment, to your profile. Outcome: operator data pack and integration assessment.

Capability program

Squadron-, unit- or dropzone-scale deployment with sustainment and analytics. Outcome: in-service capability.

The position

No incumbent supplier operates a unified hardware, software and validation platform engineered for the human at altitude. Sixty years of aerospace medicine has established what happens to people above 25,000 ft. The instrumentation to act on it in real time has existed for a decade. What is missing is a platform that puts the two together and treats the operator as a system worth measuring.

References

Sources

  1. Hundemer GL et al. Altitude decompression sickness incidence among U-2 pilots: 1994–2010. Aviat Space Environ Med 2012;83:968–74.
  2. Jersey SL et al. Neurological altitude DCS among U-2 pilots: 2002–2009. Aviat Space Environ Med 2011;82:673–82.
  3. Jersey SL et al. Severe neurological DCS in a U-2 pilot. Aviat Space Environ Med 2010;81:64–8.
  4. McGuire SA et al. Hyperintense white matter lesions in 50 high-altitude pilots with neurologic DCS. Aviat Space Environ Med 2012;83:1117–22.
  5. McGuire SA et al. Lower neurocognitive function in U-2 pilots. Neurology 2014.
  6. Eiken O, Elia A, Gottschalk F, Gennser M, Ånell R. Decompression strain in parachute jumpmasters during simulated high-altitude missions. Eur J Appl Physiol 2023.
  7. Ottestad W et al. Acute hypoxia in a simulated high-altitude airdrop scenario due to oxygen system failure. J Appl Physiol 2017.
  8. Webster AP, Reynolds OE. Time of consciousness during exposure to various pressure altitudes. US Navy BuMed 1946; FAA AC 61-107B.
  9. US Navy Physiological Episodes Action Team root-cause findings, 2020; NAVAIR 2019.
Get the full picture

Request the full technical whitepaper

The full technical whitepaper includes protocol specifications, sensor validation data and integration requirements.

Request the full technical whitepaper

SUBSCRIBE TO EXPLORE WITH US

Mission updates, platform news and partnership announcements.